Adalimumab and ixekizumab show comparable effectiveness in improving joint outcomes and achieving remission in patients with psoriatic arthritis over 12 months, according to a real-world study.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/adalimumab-and-ixekizumab-show-similar-joint-related-2026a1000a3u?src=rss
Author :
Publish date : 2026-04-06 12:00:00
Copyright for syndicated content belongs to the linked Source.